3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 1/2
2
Phase 1
1
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
42
Genitourinary
38
Gastrointestinal
34
Other hematologic neoplasm
32
Breast
32
Lymphoid
31
Gynecologic
18
Plasma cell
15
Classical hematology
11
Dermatologic
10
Myeloid
7
Endocrine
5
Sarcoma
4
Head & Neck
4
CNS
3
Tumor-Agnostic
2
NET
2
Other solid neoplasm
1
Conditions
Neoplasm Metastasis
1
Carcinoma
1
Interventions
margetuximab
1
atezolizumab
1
Trastuzumab
1
Pemetrexed
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Has announcements
×
Tumor-Agnostic
×
Clear all
NCT02492711
2025-03-17
SOPHIA
MacroGenics
Phase 3
Completed
624 enrolled
17 charts
1 FDA
NCT02367781
2021-08-09
IMpower130
Hoffmann-La Roche
Phase 3
Completed
723 enrolled
28 charts
1 FDA